RxDoctor Payments Data

John Borzok, DPM

Foot & Ankle Surgery · Englewood, NJNPI 1629422118

Payments from drug & device makers

$11,262in general payments, 2019–2025

Across 135 payments — averaging $83.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$6K
  • Stryker$2K
  • Kerecis Limited$638
  • Amgen$497
  • Treace Medical Concepts, Inc.$433
  • Integra Lifesciences Corporation$385
  • plus $1K from 19 others

What the payments were for

  • Consulting fees$1,75016%
  • Travel & lodging$3,00627%
  • Food & beverage$6,50758%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,262 in reported general payments places this provider in the 85th percentile of 542 foot & ankle surgery providers in New Jersey.

See all foot & ankle surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$111,814
Medicare patients
516
Services billed
1,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort25$1,233
Ketoconazole43$859
Ammonium Lactate34$810
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip38$607
Clotrimazole18$385
Diclofenac Sodium19$354
Nitroglycerin PatchNitroglycerin11$230
Terbinafine Hcl20$174
Methylprednisolone20$152
Gabapentin12$147
Meloxicam18$71

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Englewood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →